ArticleOncology and therapy2024

Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis.

Mirosława Püsküllüoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.